BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 12750289)

  • 21. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene.
    Maehara K; Uekawa N; Isobe K
    Biochem Biophys Res Commun; 2002 Jul; 295(1):187-92. PubMed ID: 12083788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
    Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction with Sp1 and reduction in the activity of histone deacetylase 1 are critical for the constitutive gene expression of IL-1 alpha in human melanoma cells.
    Enya K; Hayashi H; Takii T; Ohoka N; Kanata S; Okamoto T; Onozaki K
    J Leukoc Biol; 2008 Jan; 83(1):190-9. PubMed ID: 17906119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
    Sekhavat A; Sun JM; Davie JR
    Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site.
    Gao J; Chen T; Liu J; Liu W; Hu G; Guo X; Yin B; Gong Y; Zhao J; Qiang B; Yuan J; Peng X
    Glia; 2009 Jul; 57(9):989-99. PubMed ID: 19062177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of truncated form of tenascin-X (XB-S) through dissociation of HDAC1 from SP-1/HDAC1 complex in response to hypoxic conditions.
    Kato A; Endo T; Abiko S; Ariga H; Matsumoto K
    Exp Cell Res; 2008 Aug; 314(14):2661-73. PubMed ID: 18588874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription.
    Wang CH; Chang HC; Hung WC
    J Cell Physiol; 2006 Jul; 208(1):246-52. PubMed ID: 16575904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MMP28 gene expression is regulated by Sp1 transcription factor acetylation.
    Swingler TE; Kevorkian L; Culley KL; Illman SA; Young DA; Parker AE; Lohi J; Clark IM
    Biochem J; 2010 Apr; 427(3):391-400. PubMed ID: 20144149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of the conserved CCAAT and GC boxes of the human and mouse type II transforming growth factor-beta receptor genes.
    Bernadt CT; Rizzino A
    Mol Reprod Dev; 2003 Aug; 65(4):353-65. PubMed ID: 12840808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
    Klan N; Seuter S; Schnur N; Jung M; Steinhilber D
    Biol Chem; 2003 May; 384(5):777-85. PubMed ID: 12817474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells.
    Hernandez M; Shao Q; Yang XJ; Luh SP; Kandouz M; Batist G; Laird DW; Alaoui-Jamali MA
    Prostate; 2006 Aug; 66(11):1151-61. PubMed ID: 16652385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.
    Sowa Y; Orita T; Minamikawa-Hiranabe S; Mizuno T; Nomura H; Sakai T
    Cancer Res; 1999 Sep; 59(17):4266-70. PubMed ID: 10485470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trichostatin A blocks TGF-beta-induced collagen gene expression in skin fibroblasts: involvement of Sp1.
    Ghosh AK; Mori Y; Dowling E; Varga J
    Biochem Biophys Res Commun; 2007 Mar; 354(2):420-6. PubMed ID: 17234156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells.
    Kim YH; Park JW; Lee JY; Kwon TK
    Carcinogenesis; 2004 Oct; 25(10):1813-20. PubMed ID: 15142888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer.
    Dressel U; Renkawitz R; Baniahmad A
    Anticancer Res; 2000; 20(2A):1017-22. PubMed ID: 10810390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
    Ko Y; Banerji SS; Liu Y; Li W; Liang J; Soule HD; Pauley RJ; Willson JK; Zborowska E; Brattain MG
    J Cell Physiol; 1998 Aug; 176(2):424-34. PubMed ID: 9648930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
    Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IFI16 in human prostate cancer.
    Alimirah F; Chen J; Davis FJ; Choubey D
    Mol Cancer Res; 2007 Mar; 5(3):251-9. PubMed ID: 17339605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sp1 is a transcription repressor to stanniocalcin-1 expression in TSA-treated human colon cancer cells, HT29.
    Law AY; Yeung BH; Ching LY; Wong CK
    J Cell Biochem; 2011 Aug; 112(8):2089-96. PubMed ID: 21465530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.